Skip to content

Core Scientific

US · CORZ #2073 by market cap Listed 2024
11.33 -2.03 -15.19%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 13.05 -2.33%
After-hours 11.75 +3.74%
Overnight 13.03 -2.47%
29.1611.3311.332026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on CORZ?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -31.8% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 22.7% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days E → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall F

The radar needs all six factors. Available grades are shown below.

Valuation D-

How expensive the stock is versus earnings, sales and its own 5-year history.

Forward P/E 29.7x Better than 18%
Price / Sales 7.9x Better than 13%
Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability D-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 11.9% Better than 8%
Operating margin -70.4% Better than 8%
Net margin -90.5% Better than 7%
Return on equity -17.6% Better than 17%
Return on invested capital -17.6% Better than 14%
Momentum D

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -36.4% Better than 13%
6-month return -55.1% Better than 6%
12-month return (ex latest month) -10.4% Better than 22%
Distance below 52-week high 62.8% Better than 9%
Financial Health F

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.1x Better than 27%
Debt to assets 49.5% Better than 16%
Interest coverage -34.5x Better than 8%
Analyst View A

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 149.3% Better than 90%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -21.97%
1M -17.84%
3M -38.39%
6M -51.12%
YTD -22.18%
1Y -25.26%

Key statistics

Price & volume

Prev close
13.36
Open
12.93
Day range
11.26 - 12.99
Avg price
11.71
Volume
22.28M
Turnover
260.81M
Amplitude
12.91%
52-week range
10.59 - 30.46

Valuation

P/E
-12.88
P/E (TTM)
-34.33
P/B
-3.34
EPS
-0.88
Net profit
-283.57M
Net assets
-1.09B

Share structure

Market cap
3.65B
Float cap
3.14B
Shares out
322.24M
Float shares
276.84M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2024-01-24
52-week range 4% of range
10.59 30.46

62.8% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-24.86M net over the window

Short interest

Shares short
73.01M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Core Scientific (CORZ)?

Core Scientific last traded at 11.33. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Core Scientific's market cap?

About 3.65B.

What is the P/E ratio of Core Scientific?

The trailing twelve-month P/E is -34.33. The Valuation tab shows it against the stock's own five-year range.

Does Core Scientific pay a dividend?

Core Scientific does not currently pay a regular dividend.

Is Core Scientific a buy according to analysts?

The consensus of 12 analysts is a Buy rating, with an average 12-month price target of 28.25, which implies 149.3% upside from the current price. This is not investment advice.

What is Core Scientific's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Core Scientific a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 20:02:35 · For reference only, not investment advice and not tailored to your situation.

Core Scientific discussion 0 comments

Add a comment